Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferasirox gastrointestinal tolerability before versus after meals in transfusional haemosiderosis
2010-023217-61Phase 4Terminated
- Sponsor
- University College London
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of deferasirox in hemosiderosis and iron overload (2 arms), sponsored by University College London. Primary endpoint: Change in Gastrointestinal Quality of Life Index in established deferasirox cohort. Started Jan 2012; status: terminated.
02
Drugs
deferasirox
03
Conditions
hemosiderosisiron overload
Beyond the preview
Go deeper on 2010-023217-61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023217-61.